Ipswich Investment Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$1.88M |
| 2 |
Fluor
FLR
|
+$1.51M |
| 3 |
Oracle
ORCL
|
+$1.33M |
| 4 |
Automatic Data Processing
ADP
|
+$361K |
| 5 |
AbbVie
ABBV
|
+$301K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American International
AIG
|
+$2.73M |
| 2 |
Procter & Gamble
PG
|
+$1.91M |
| 3 |
Gilead Sciences
GILD
|
+$1.61M |
| 4 |
Microsoft
MSFT
|
+$1.46M |
| 5 |
Chevron
CVX
|
+$1.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.67% |
| 2 | Energy | 13.69% |
| 3 | Industrials | 13.6% |
| 4 | Technology | 12.43% |
| 5 | Financials | 12.36% |
Similar funds
Ipswich Investment Management's Q2 2017 Portfolio in Review
As of Q2 2017, Ipswich Investment Management held 140 positions worth $213M, down 7% from $230M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ipswich Investment Management withdrew a net $19.6M in Q2 2017, closing 6 positions and reducing 67 holdings. Its most notable exit was American International, an estimated $2.73M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Energy and Industrials.
Against the trend, Ipswich Investment Management opened a new position in Marsh worth $1.94M.
- Ipswich Investment Management's largest Q2 2017 buy was Marsh: 24,880 shares worth $1.94M.
- Ipswich Investment Management added most to Oracle in Q2 2017, an estimated $1.33M increase.
- Ipswich Investment Management's biggest Q2 2017 reduction was Procter & Gamble, cutting an estimated $1.91M.
- Ipswich Investment Management fully exited American International in Q2 2017, selling an estimated $2.73M.
- Ipswich Investment Management's ten largest holdings make up 29% of its $213M portfolio in Q2 2017.
- Ipswich Investment Management opened 9 new positions and closed 6 in Q2 2017.
- Ipswich Investment Management's portfolio value fell 7% quarter-over-quarter to $213M.
Based on Ipswich Investment Management's 13F filing for Q2 2017, filed 21 Jul 2017.